PRKX-mediated stabilization of PD-L1 characterizes an immunosuppressive gastric cancer subtype
Abstract Background Gastric cancer (GC) derives limited benefit from immunotherapy, with clinical responses observed in only a minority of patients. Increasing evidence suggests that heterogeneity within the tumor immune microenvironment (TME) is a critical determinant of immunotherapeutic efficacy, highlighting the ne...